tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tandem Diabetes assumed with an Outperform at Oppenheimer
PremiumThe FlyTandem Diabetes assumed with an Outperform at Oppenheimer
1M ago
Tandem announces Health Canada authorization for t:slim mobile application
Premium
The Fly
Tandem announces Health Canada authorization for t:slim mobile application
1M ago
Tandem Diabetes price target raised to $11 from $10.35 at Citi
Premium
The Fly
Tandem Diabetes price target raised to $11 from $10.35 at Citi
2M ago
Tandem Diabetes downgraded to Hold from Buy at Lake Street
PremiumThe FlyTandem Diabetes downgraded to Hold from Buy at Lake Street
2M ago
Tandem Diabetes price target lowered to $51 from $53 at Barclays
Premium
The Fly
Tandem Diabetes price target lowered to $51 from $53 at Barclays
2M ago
Positive Outlook for Tandem Diabetes Care: Buy Rating Reaffirmed Amid Growth Catalysts and Strategic Opportunities
Premium
Ratings
Positive Outlook for Tandem Diabetes Care: Buy Rating Reaffirmed Amid Growth Catalysts and Strategic Opportunities
2M ago
Tandem Diabetes announces medical device correction for t:slim X2 insulin pumps
PremiumThe FlyTandem Diabetes announces medical device correction for t:slim X2 insulin pumps
2M ago
Tandem Diabetes downgraded to Hold from Buy at Nephron Research
Premium
The Fly
Tandem Diabetes downgraded to Hold from Buy at Nephron Research
2M ago
Tandem Diabetes price target lowered to $13 from $20 at Wells Fargo
Premium
The Fly
Tandem Diabetes price target lowered to $13 from $20 at Wells Fargo
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100